The graphical representation of changes in the mean serum levels of IL-4, IL-5, and IL-13 was analyzed in AD, AA, and AR among biotreated (BT) versus Bio-Naïve (BN) SPA patients (Figure 5a–c). This evidence concerns the gene IL5 and Alzheimer disease.